You are here

CagriSema

Novo Nordisk plans new study for CagriSema, targets 2026 submission

Clinical Trials Arena

Fri, 02/7/25 - 11:42 am

clinical trials

Investors seek answers on Novo Nordisk's next-gen obesity drug CagriSema

Yahoo/Reuters

Tue, 02/4/25 - 06:11 pm

Novo Nordisk commences fresh trials for CagriSema

Devdiscourse

Thu, 01/30/25 - 11:33 am

clinical trials

Launches from Novo, Lilly top Clarivate's annual 'Drugs to Watch' list

Fierce Pharma

Wed, 01/8/25 - 11:20 pm

Novo’s next-gen obesity drug misses expectations in closely watched trial

BioPharma Dive

Fri, 12/20/24 - 11:34 am

clinical trials

Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch.

BioPharma Dive

Fri, 10/11/24 - 11:10 am

Skye Bioscience

5 Obesity Readouts to Watch in the Second Half of 2024

BioSpace

Tue, 08/13/24 - 11:47 am

clinical trials

Terns Pharmaceuticals

4 Investigational Weight Loss Drugs That Could Change the Market

BioSpace

Mon, 04/15/24 - 11:09 am

Viking Therapeutics

Inversago Pharma

Novo Nordisk fights back at Lilly with Wegovy combo trial against Zepbound in obesity

https://bit.ly/49zNkYL

Wed, 11/15/23 - 12:04 pm

clinical trials

Novo Nordisk successfully completes phase 2 trial with CagriSema in people with type 2 diabetes

Yahoo Finance

Mon, 08/22/22 - 10:00 am

clinical trials

type 2 diabetes